New experimental models of the blood-brain barrier for CNS drug discovery
- PMID: 27782770
- PMCID: PMC5521006
- DOI: 10.1080/17460441.2017.1253676
New experimental models of the blood-brain barrier for CNS drug discovery
Abstract
The blood-brain barrier (BBB) is a dynamic biological interface which actively controls the passage of substances between the blood and the central nervous system (CNS). From a biological and functional standpoint, the BBB plays a crucial role in maintaining brain homeostasis inasmuch that deterioration of BBB functions are prodromal to many CNS disorders. Conversely, the BBB hinders the delivery of drugs targeting the brain to treat a variety of neurological diseases. Area covered: This article reviews recent technological improvements and innovation in the field of BBB modeling including static and dynamic cell-based platforms, microfluidic systems and the use of stem cells and 3D printing technologies. Additionally, the authors laid out a roadmap for the integration of microfluidics and stem cell biology as a holistic approach for the development of novel in vitro BBB platforms. Expert opinion: Development of effective CNS drugs has been hindered by the lack of reliable strategies to mimic the BBB and cerebrovascular impairments in vitro. Technological advancements in BBB modeling have fostered the development of highly integrative and quasi- physiological in vitro platforms to support the process of drug discovery. These advanced in vitro tools are likely to further current understanding of the cerebrovascular modulatory mechanisms.
Keywords: In vitro; alternative; brain; brain disorders; cell culture; cerebrovascular; drug testing; permeability; technology.
Figures
Similar articles
-
Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.Expert Opin Drug Discov. 2015 Feb;10(2):141-55. doi: 10.1517/17460441.2015.974545. Epub 2014 Nov 12. Expert Opin Drug Discov. 2015. PMID: 25388782 Review.
-
Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D.Mini Rev Med Chem. 2017;17(3):247-257. doi: 10.2174/1389557516666161013110813. Mini Rev Med Chem. 2017. PMID: 27739359 Review.
-
From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.Nat Rev Drug Discov. 2016 Apr;15(4):275-92. doi: 10.1038/nrd.2015.21. Epub 2016 Jan 22. Nat Rev Drug Discov. 2016. PMID: 26794270 Review.
-
From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.Eur J Pharm Sci. 2015 Jul 10;74:63-76. doi: 10.1016/j.ejps.2015.04.005. Epub 2015 Apr 16. Eur J Pharm Sci. 2015. PMID: 25892455 Review.
-
Blood-brain barrier: an impediment to neuropharmaceuticals.Clin Pharmacol Ther. 2015 Apr;97(4):308-13. doi: 10.1002/cpt.77. Epub 2015 Feb 24. Clin Pharmacol Ther. 2015. PMID: 25670372
Cited by
-
Modeling blood-brain barrier pathology in cerebrovascular disease in vitro: current and future paradigms.Fluids Barriers CNS. 2020 Jul 16;17(1):44. doi: 10.1186/s12987-020-00202-7. Fluids Barriers CNS. 2020. PMID: 32677965 Free PMC article. Review.
-
Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway.BMC Infect Dis. 2022 Oct 5;22(1):774. doi: 10.1186/s12879-022-07752-1. BMC Infect Dis. 2022. PMID: 36199030 Free PMC article.
-
The Progress in Molecular Transport and Therapeutic Development in Human Blood-Brain Barrier Models in Neurological Disorders.Cell Mol Neurobiol. 2024 Apr 16;44(1):34. doi: 10.1007/s10571-024-01473-6. Cell Mol Neurobiol. 2024. PMID: 38627312 Free PMC article. Review.
-
A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine.Acta Pharm Sin B. 2021 Jun;11(6):1379-1399. doi: 10.1016/j.apsb.2021.03.024. Epub 2021 Mar 20. Acta Pharm Sin B. 2021. PMID: 34221858 Free PMC article. Review.
-
Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition.PLoS One. 2018 May 15;13(5):e0197379. doi: 10.1371/journal.pone.0197379. eCollection 2018. PLoS One. 2018. PMID: 29763456 Free PMC article.
References
-
- Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001;24:719–25. - PubMed
-
- Huber JD, Witt KA, Hom S, et al. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol. 2001;280:H1241–8. - PubMed
-
- Tilling T, Engelbertz C, Decker S, et al. Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures. Cell Tissue Res. 2002;310:19–29. - PubMed
-
- Rosenberg GA, Kornfeld M, Estrada E, et al. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 1992;576:203–7. - PubMed
-
- Liberto CM, Albrecht PJ, Herx LM, et al. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem. 2004;89:1092–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources